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Abstract
In recent years, microfluidic systems have been used to study fundamental aspects of angiogenesis through the patterning
of single-layered, linear or geometric vascular channels. In vivo, however, capillaries exist in complex, three-dimensional (3D)
networks, and angiogenic sprouting occurs with a degree of unpredictability in all x,y,z planes. The ability to generate
capillary beds in vitro that can support thick, biological tissues remains a key challenge to the regeneration of vital organs.
Here, we report the engineering of 3D capillary beds in an in vitro microfluidic platform that is comprised of a
biocompatible collagen I gel supported by a mechanical framework of alginate beads. The engineered vessels have patent
lumens, form robust ,1.5 mm capillary networks across the devices, and support the perfusion of 1 mm fluorescent beads
through them. In addition, the alginate beads offer a modular method to encapsulate and co-culture cells that either
promote angiogenesis or require perfusion for cell viability in engineered tissue constructs. This laboratory-constructed
vascular supply may be clinically significant for the engineering of capillary beds and higher order biological tissues in a
scalable and modular manner.
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Introduction
The single most pressing challenge in the fields of tissue
engineering and regenerative medicine has been the understand-
ing and control of vascularization [1]. In vivo, capillary networks
deliver oxygen and nutrients to thick (.1–2 mm) tissues which
cannot be supported by passive diffusion [2]. Likewise, in
pathophysiological conditions, malignant tumors flip an ‘‘angio-
genic switch,’’ inducing the formation of abnormal vasculature to
support the increased tumor density [3]. There currently exists an
enormous clinical demand for engineered soft tissue to treat
peripheral artery diseases and myocardial ischemia, and also for
the long-term prospect of regenerating vital organs, including the
liver, kidney, and heart [4,5]. For these clinical applications to be
possible, a preformed in vitro internal vascular supply will be
required to maintain the viability of laboratory-engineered tissues
and organs with dimensions greater than a few hundred
micrometers [4,5].
Recent advances in cell biology combined with new technol-
ogies to manipulate cell behavior have led to a new field where
biological systems are miniaturized within microfluidic systems
[6,7]. Researchers have developed microfluidic platforms to study
fundamental aspects of angiogenesis and thrombosis in vitro [8,9],
such as real-time imaging of anastomoses [10], and the
contribution of interstitial pressure to angiogenic sprouting [11].
While these systems are highly informative experimentally, the
capillary channels designed in these studies are single-layered
vessels that lie at 90-degree angles to each other or in parallel, and
do not closely model physiologic capillaries. In vivo, both
physiologic and pathologic networks respond to angiogenic signals
and sprout to form complex, three-dimensional (3D) capillary beds
in multiple planes [12]; These capillary beds are multi-layered,
undergo repeated branching, and sprout along random paths [13].
Using the same core technology of microfabrication, we built
the blueprint for a capillary bed into a biodegradable gel scaffold.
Here, the microfluidic platform consists of a collagen matrix
embedded with alginate microbeads, and the alginate beads form
the 3D architecture and compartmentalization of other cell types
that interact with the capillary bed. Human microvascular
endothelial cells (hMVECs) seeded in channels were encouraged
to sprout with either an exogenous supply of growth factors, or by
the encapsulation of highly angiogenic cell lines that secrete
growth factors. Capillaries sprouted in 1–2 days and reached
invasion depths of ,1.25 mm within one week. The vascular bed
produced using this microfluidic platform was capillary-like in
scale, structure, and function. It possessed the ‘‘tree-like’’ structure
of native microvasculature, and supported the perfusion of 1 mm
diameter particles through patent lumens.
The objective of our study was to design 3D capillary networks
that address three key requirements of a vascular construct. First,
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the vascular construct should allow for the highly organized
incorporation of multiple cell types, which ideally should be within
,100–200 mm of a microvessel [2]. Here, the small dimensions of
the alginate beads (152.5633.4 mm) and the interconnected
vascular channels are expected to provide good nutrient and
oxygen supply to encapsulated cells. Second, the construct should
be fabricated with a scalable strategy in mind, as larger constructs
will eventually be necessary to engineer whole organs comprised of
densely-packed, metabolically-active cells [14]. In our design,
alginate beads encapsulating different cell types can be assembled
into any overall size and shape in controlled bead ratios and cell
densities, and be functionally connected to a larger caliber vessel to
generate a perfused vascular bed. Third, the construct should be
designed with a biocompatible scaffold that is U.S. Food and Drug
Administration (FDA)-approved for cell-based therapy. Collagen I
[15] and alginate [16] are both FDA-approved biomaterials and
have been used in various tissue-engineering applications (e.g.
AlgiMatrix, Covalon matrix) [17].
In summary, we have designed, built, and tested a laboratory-
generated capillary bed which shows robust capillary growth with
patent lumens, and forms complex, anastomosing capillary
networks that support flow. These large, vascularized tissue
constructs on the millimeter scale provide the basic architecture
to design thicker tissues that go beyond the diffusion limit. The
ultimate goal is to scale up the technology into a full, 3D system
with the blood volume and cell densities required for a complete




Human dermal fibroblasts, HDF, and a human fibrosarcoma
cell line, HT-1080 (American Type Culture Collection (ATCC),
Manassas, VA), were cultured in Dulbecco’s modified Eagle’s
medium containing 4.5 g/l glucose (DMEM, Sigma-Aldrich, St
Louis, MO), supplemented with L-glutamine, penicillin (100
units/ml), streptomycin (100 mg/ml), and 10% fetal bovine serum
(Sigma-Aldrich). hMVECs (Lonza, Williamsport, PA) were
cultured in collagen I-treated culture flasks in microvascular
endothelial medium-2 (EGM-2MV, Lonza), supplemented with an
EGM-2 bullet kit (Lonza). All cells were routinely cultured at 37uC
in a humidified incubator containing 5% CO2/95% air. HT-1080
and HDF were used up to passage 25 and hMVECs were used at
passage 6–8. Medium was changed three times per week and cells
were harvested with trypsin-EDTA (Gibco). In devices where
more than one cell type was present, both cell types were cultured
in hMVEC complete culture medium.
hMVEC Transfection with Reporter Plasmid
For live-imaging studies, hMVECs were transfected with a
pMSCV-puromycin vector containing mCherry gene sequences
(MSCV Retroviral Expression System, Clontech Laboratories
Inc., Mountain View, CA). Briefly, DNA complexes were
prepared by incubating 18 ml of Fugene 6 (Roche Diagnostics,
Indianapolis, IN) in 600 ml Opti-MEM reduced serum media
(Invitrogen, Grand Island, NY) for 5 min at room temperature,
before mixing in 4 mg of plasmid DNA, 0.4 mg of gag/pol DNA,
and 2.5 mg of VSV-G DNA (all from Clontech) by gentle flicking.
The DNA complexes were added to a 293T packaging cell line
(Clontech) cultured in DMEM and 10% fetal bovine serum and
gently mixed by swirling. After incubation for 18 h at 37˚ C, viruses
were harvested from the medium using a 20 ml syringe, and
filtered using a 0.45 mm syringe filter. Viruses were aliquoted and
frozen at 280uC or used immediately. For hMVEC transfection,
the viral supernatant was mixed with 10 ug/ml protamine sulfate
(Sigma-Aldrich) from a 3 mg/ml stock solution in PBS. An early
hMVEC passage (p 4–5) was incubated with a 1:1 mix of viral
supernatant and complete EGM-2MV medium. The infection was
repeated 24 h later to increase the number of hMVECs that were
transfected without a positive selection step.
Wafer Fabrication
Microfluidic devices were fabricated using photolithography
and soft-lithography techniques [18]. The device design was
created in AutoCAD 2009 (Autodesk, San Rafael, CA) and the
negative pattern of the device was printed onto a transparency
mask with a high-resolution printer. Standard photolithography
was employed for wafer processing (Seoulin Biosciences, Seoul,
South Korea). Briefly, a SU-8 photoresist was spin-coated on clean
silicon wafers at a thickness of 120 mm. Following a pre-bake, the
mask was placed over the wafer and the assembly was exposed to
ultraviolet (UV) light, causing the photoresist to be photopolymer-
ized where exposed. To achieve a 240 mm z-axis, a second layer
was made by secondary spin coating and exposure. Next, the
wafer was developed, hard-baked, washed with acetone, and dried
using compressed air. Wafers were silanized to facilitate removal of
replica material, and microfluidic devices were made by replica
molding of polydimethylsiloxane, PDMS, (Sylgard 184, Dow
Corning, Midland, MI) using a 10:1 ratio of base to curing agent.
After degassing the elastomer mix in a vacuum chamber, the mix
was poured onto the wafer and cured in an 80uC oven overnight.
Polymerized PDMS devices were peeled off the silicon master,
individual devices (30 mm diameter, 10 mm height) were cut from
PDMS molds, and inlet and outlet ports were cored down to
microfluidic channels using standard 4 mm biopsy punches. Prior
to cell culture use, PDMS devices were air-dusted with compressed
air, autoclaved at 120uC using a wet cycle (20 min sterilization),
and dry cycle (20 min sterilization/15 min dry). Circular glass
coverslips were similarly air-dusted with compressed air, and
autoclaved at 120uC using a dry cycle (20 min sterilization/
15 min dry). PDMS devices and glass coverslips were plasma
treated (Harrick Expanded Plasma Cleaner, Harrick Plasma,
Ithaca, NY) for 2 min. Surface treatment renders the PDMS
surface and coverslip hydrophilic, ensuring a tight bond and
preventing leaks.
Alginate Bead Formation
Alginate solutions of 4% (w/v) were prepared using low-
viscosity alginic acid sodium salt from brown algae (Cat#A2158,
Sigma-Aldrich) dissolved in PBS and passed through a 0.45 mm
syringe filter (BD Biosciences, Bedford, MA) to remove bacteria
and any large clumps of undissolved alginate. If cell encapsulation
is required, cells (i.e. HT-1080 fibrosarcomas) were trypsinized,
centrifuged (2006g, 5 min), and resuspended in complete DMEM
medium, before being mixed gently in a 1:1 ratio with the 4%
alginate solution in 16 PBS to give a final 2% alginate solution
and 56106 cells/ml cell density. If cell encapsulation is not
required, a 2% alginate solution was used instead. To prepare the
alginate beads, the alginate solution (with or without cells) was
loaded into a 3 ml syringe and infused using a syringe-pump
(Advance Infusion Pump Series 1200, Roboz Surgical Instruments
Co., Inc., Gaithersburg, MD) at 25 ml/h through a 30 gauge
needle (BD Biosciences) into a focused air-jet stream. The built-in
laboratory air supply was connected to TygonH laboratory tubing
and focused using a 200 mL pipette tip at a 90-degree angle to the
syringe. The alginate solution was cut using the focused air-jet
stream and beads were polymerized by calcium crosslinking in a
In Vitro 3D Capillary Beds
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15 cm petri-dish containing 100 mM CaCl2 solution below the
air-jet stream. To isolate ,150 mm diameter beads from smaller
beads and unencapsulated cells, the beads were filtered using
100 mm cell strainers (BD Biosciences) and resuspended in 3–5 ml
of DMEM. Cell-encapsulated beads were maintained in a
humidified incubator at 37uC and 5% CO2. To visualize the
alginate beads embedded within the collagen matrix, beads were
coated under gentle rocking conditions with 0.4 mg/ml of poly–L–
lysine-fluorescein isothiocyanate (PLL–FITC, MW 15,000–
30,000, P3543 from Sigma-Aldrich) in DMEM for 5 min at room
temperature. The beads were centrifuged (2006g, 5 min) twice
before mixing into the prepolymerized collagen gel.
Gel Filling of Device
Sterile PDMS devices and glass coverslips were filled with gels
within 30–60 min of surface plasma treatment. A prepolymer
collagen solution containing alginate beads was prepared on ice by
combining: rat tail collagen type I (BD Biosciences), 106 PBS
solution, 0.5 M NaOH, and 40% (v/v) alginate beads in
suspension, to produce a final collagen concentration of 2.5 mg/
ml at pH 7.4, excluding the 40% volume of alginate beads. The
alginate-collagen solution was carefully mixed 10–20 times without
introducing any air bubbles. The solution was carefully microin-
jected using a 10 ml pipette into the gel region until the six
micropillars surrounding the gel region were no longer visible
(final gel volume ,0.525 ml). After microinjection, the PDMS
Figure 1. Microfluidic device design and fabrication. (a) The microfluidic-based cell culture platform directs vascular growth along an alginate
bead scaffold to form a 3D capillary bed. The optically transparent PDMS is bonded to a glass coverslip, and the gel region is flanked by two
microfluidic channels with inlet and outlet ports for medium renewal. (b) Dimensions of the microfluidic device in mm. The gel region (1,750 mmwide,
1,250 mm long, 240 mm high) is surrounded by six square micropillars (25062506240 mm) for gel containment. (c) Microfluidic devices cultured under
static and flow conditions. (d) Schematic of 10 mm pressure drop set-up for flow analysis studies.
doi:10.1371/journal.pone.0050582.g001
In Vitro 3D Capillary Beds
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e50582
devices were immediately bonded to glass coverslips. The devices
were placed in a humidified container with the glass slide facing
downwards, and allowed to polymerize for 30 min in a 37uC
humidified incubator with 5% CO2. Finally, the microfluidic
channels were filled with cell culture medium.
hMVEC Seeding
24 h later after gel filling, hMVECs were added at a density of
26106 cells/ml to one channel of the device. The hMVECs were
allowed to attach for 60 min by flipping the devices sideways such
that the cells formed a monolayer across the gel. After 60 min of
seeding, devices were flipped back and channels were washed with
fresh culture medium. Each port was filled with an additional
60 ml culture medium to prevent evaporation. The next day,
additional 50 ng/ml VEGF165 (Peprotech, Rocky Hill, NJ) was
added to the medium to stimulate angiogenesis and proliferation.
If angiogenesis is not needed, the EGM-2 bullet kit (Lonza)
supplied VEGF165 would be sufficient for cell maintenance.
hMVEC medium was replaced daily.
Diffusion Studies
To characterize the transport of growth factors secreted by cells,
diffusion experiments were performed using different molecular
weight dextrans (Cascade Blue-conjugated, MW 10,000; FITC-
conjugated, MW 40,000; and Texas Red-conjugated, MW 70,000;
all from Invitrogen) mixed with culture medium at a final
concentration of 15 mg/ml. The fluorescent solution was added to
the condition channel while PBS was added to the other channel.
A series of fluorescent images of the gel region was acquired at
30 min intervals for 2 h using a Nikon TE300 fluorescence
microscope (Nikon Instruments Inc., Melville, NY). Image
processing of time-lapse fluorescent images was performed using
a custom written code in MATLAB (Mathworks, Boston, MA,
USA) [19]. Briefly, a vertical line was drawn through the gel
region and the fluorescence intensity was mapped to a concen-
tration profile by subtracting the background intensity value and
normalizing to the maximum intensity value in the condition
channel. The diffusion coefficients for the different molecular
weight dextrans (Figure S1) were quantified by fitting the
analytical solution of the one-dimensional transient diffusion to the
measured fluorescent intensity data.
Immunocytochemistry and Imaging
Tissue constructs were imaged 7–9 days post-assembly by both
fluorescence and confocal microscopy. The devices were washed
twice in PBS and fixed with 4% paraformaldehyde (Electron
Micoscopy Sciences, Hatfield, PA) for 20 min at room tempera-
ture. After two washes in PBS, the cells were permeabilized with
0.2% Triton X-100 for 10 min at room temperature. After three
washes in PBS, the devices were blocked with 5% goat serum in
0.5% BSA/PBS solution for 1 h at room temperature. hMVECs
were stained with rabbit anti-vascular endothelial (VE)-cadherin
antibody (ALX-210-232-C100, 100 mg/ml stock solution in
ultrapure water, Enzo Life Sciences International, Plymouth
Meeting, PA) at 1:100 dilution in 0.5% BSA/PBS solution
overnight at 4uC. The next day, the devices were washed five
times with 0.5% BSA/PBS solution and incubated with Alexa
Fluor 488-conjugated anti-rabbit IgG (P2771, 1 mg/ml, Invitro-
gen) at 1:200 dilution for 2 h at room temperature. After three
washes in 0.5% BSA/PBS, actin filaments and cell nuclei were
labeled with rhodamine phalloidin (R415, 300 U, Invitrogen) at
1:100 dilution, and 49,6-diamidino-2-phenylindole, DAPI (D8417,
1 mg/ml stock solution in ultrapure water, Sigma-Aldrich) at
1:1000 dilution for 1 h at room temperature, followed by three
washes in PBS. For 2D fluorescence imaging, images were
obtained using a Nikon TE300 fluorescence microscope described
earlier. For 3D confocal imaging, a z-axis series of fluorescence
images was obtained using a Zeiss 510n confocal laser scanning
microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA).
1 mm thick ,150–200 optical serial z-axis sections were obtained
and reconstructed in 3D using Imaris 7.1.1 software (Bitplane Inc.,
Saint Paul, MN).
Figure 2. Alginate-collagen hydrogels as a blueprint for 3D capillary bed design. (a) Phase contrast image of the alginate-collagen gel
region. The alginate beads form 40% of the gel volume. (b) Fluorescent image of the alginate-collagen gel region using PLL–FITC coated alginate
beads. Scale bars, 250 mm (a, b).
doi:10.1371/journal.pone.0050582.g002
In Vitro 3D Capillary Beds
PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e50582
Cell Viability Assays
Cell viability assays in microfluidic devices: Cells in alginate
beads were labeled live/dead using a LIVE/DEAD Reduced
Biohazard Cell Viability Kit (Invitrogen) according to the
manufacturer’s instructions. Briefly, the devices were incubated
in 240 ml of Hank’s buffered salt solution containing the live/dead
stain for 30 min at room temperature in the dark. The distribution
of green (live) and red (dead) cells was visualized using a TE300
Nikon fluorescence microscope at 46magnification.
Cell viability assays in solution: The trypan blue exclusion
method was used to quantify the number of live cells in the
alginate beads. 500 ml of cell encapsulated alginate beads were
dissolved in 55 mM sodium citrate (Sigma-Aldrich) and placed on
a hemocytometer. Cells that had trypan blue exclusion were
counted as viable cells, and percentage cell viability was
determined from n = 5 samples, ,30 cells per field of view.
hMVEC Sprouting Coculture Studies with HT-1080
Alginate Beads
HT-1080 cells were encapsulated in alginate beads, and mixed
with collagen I gels using the standard gel filling procedure. 24 h
after gel filling, hMVECs were seeded at a density of 26106 cells/
ml in one channel of the device, and allowed to attach for 60 min
by flipping the device perpendicularly. Subsequently, the cell
medium was replaced with a basal microvascular endothelial
medium-2 (EGM-2MV) that was not supplemented with addi-
tional growth factors. The medium was changed at 24 h intervals.
At 72 h after hMVEC seeding, the lengths of four of the longest
sprouts per device were measured and averaged among n = 7
devices per condition using ImageJ software (NIH).
Statistical Analysis
Error bars represent standard deviation, with n $ 3 for all
experiments. Statistical significance was determined using one-way
ANOVA followed by Tukey’s Multiple Comparison Test
(P,0.05). All statistical analysis was performed using Origin 7.0
data analysis software (OriginLab, Northampton, MA).
Results
Microfluidic Device Fabrication and Assembly
The alginate-collagen hydrogel device consists of molded
silicone rubber (polydimethylsiloxane, PDMS) bonded to a glass
coverslip, with a central gel region flanked by two microfluidic
channels supplied by four inlet/outlet ports [20]. Fig. 1a shows a
schematic of the microfluidic device and Fig. 1b provides its
dimensions. The microfluidic devices can support both static and
Figure 3. Effects of scaffolding on the 3D properties of the capillary bed. Phase contrast images of hMVECs in (a) collagen and (b) alginate-
collagen gels on Day 3 of hMVEC seeding. Confocal microscopy images of hMVECs in (c) collagen and (d) alginate-collagen gels on Day 7 of hMVEC
seeding stained for vascular endothelial (VE)-cadherin (green) and cell nuclei (blue). Scale bars, 250 mm (a, b), 100 mm (c, d).
doi:10.1371/journal.pone.0050582.g003
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flow conditions (Fig. 1c), and flow studies were carried out using a
pressure drop as shown in the schematic (Fig. 1d).
To assemble the device, a composite hydrogel consisting of
alginate beads (40% gel volume) in 2.5 mg/ml collagen I (final
collagen concentration) was filled into the gel region by
microinjection (volume of gel region = 0.525 ml) to give 119610
alginate beads per gel region (n = 4 devices) (Fig. 2a). During the
gel filling process, the gel is constrained within the gel region by six
micropillars (25062506240 mm). The average size distribution of
the alginate beads after size filtration was 152.5633.4 mm using
ImageJ analysis of ,30 beads per section (n = 4 devices), a size
range both suitable for gel filling and the diffusion of nutrients and
oxygen to encapsulated cells. To visualize the alginate beads
embedded within the collagen matrix, the beads were coated with
poly–L–lysine-fluorescein isothiocyanate (PLL–FITC, MW
15,000–30,000) before mixing into the prepolymerized collagen
gel. A representative z-section of the gel region taken by confocal
microscopy is shown in Fig. 2b.
Analysis of Diffusion Properties Across Alginate-collagen
Gels
An initial concern was that the collagen would not polymerize
completely when 40% of the gel volume was alginate. In Fig. S1,
we collected images of diffusion gradients produced with FITC–
dextran of different sizes (MW 10,000 to 70,000) across these gels.
Barring the uneven fluorescence intensity profile across the
alginate-collagen gels, both the collagen-only and collagen-alginate
gels produced comparable diffusion gradients at 2 h (Fig. S1a,
b). The diffusion coefficient of the 40 kDa dextran across the
alginate-collagen gel at DALG–COL = 2.09610
211 m2/s is lower
than for the 2.5 mg/ml collagen I gel at DCOL = 2.54610
211 m2/
s, as dextran diffusion is hindered by the smaller diffusion
coefficient of alginate (Fig. S1c). A complete set of diffusion
profiles and coefficients can be found in Fig. S1. Hence, the
alginate-collagen gel maintains the original barrier function of
collagen, with added features of scaffolding and spatially-restricted
cocultures.
Characteristics of the 3D Microcapillary Bed Produced
with an Alginate-collagen Scaffold
Preliminary experiments were carried out to explore conditions
that led to angiogenic sprouting. Highly angiogenic conditions
were achieved with hMVEC medium containing angiogenic
factors (e.g. FGF-b, IGF-1, EGF), and supplemented with
50 ng/ml recombinant human vascular endothelial growth factor
isoform (VEGF165). The collagen concentration used in the study
was also important for controlling angiogenic sprouting. 2 mg/ml
alginate-collagen gels (0.2%) resulted in rapid hMVEC sprouting;
in contrast, 3 mg/ml (0.3%) alginate-collagen gels resulted in
limited hMVEC sprouting. Hence, 2.5 mg/ml (0.25%) collagen
gels polymerized at pH 7.4 were used in all experiments.
Examination of phase contrast and immunofluorescent images
of collagen-only gels (Fig. 3a, c) against alginate-collagen gels
(Fig. 3b, d) showed a marked dependence of the vascular 3D
features on the architecture provided by the beads. The speed of
hMVEC sprouting was also improved in the presence of the
alginate beads comparing representative images taken on Day 3
and Day 7 (Fig. 3). hMVEC angiogenic sprouting in collagen-only
gels was inadequate along the z-axis, defined as the distance from
the bottom of the device to which sprouts penetrate divided by the
total height of the gel region, expressed as a percentage (D,
sprouting along z-axis), DCOL = 24.468.83% vs. DALG–
COL = 65.569.42% (p,0.005, n = 8 devices). In collagen-only
gels, the hMVECs preferentially migrated along the glass coverslip
at the bottom of the device, resulting in approximately 75% of the
gel region remaining nonvascularized. In alginate-collagen gels,
however, the capillary bed extended along the z-axis, covering
more than 65% of the gel region. Our measurements showed that
the median vessel diameter was 15 mm (mean: 18.569.5 mm,
n = 40), taken midway between bifurcation points from phase
contrast images of the devices. Only vessels that were in focus and
Figure 4. Confocal microscopy reconstruction of the 3D capillary bed. (a) Reconstructed z-stack at 406magnification on Day 7 of hMVEC
seeding. (b) Cross-sectional profile of the z-stack shows lumens on both the x,y-axis planes (VE-cadherin, green; actin, red; cell nuclei, blue). Dotted
lines indicate where the PDMS micropillars are located. Scale bars, 50 mm (a, b).
doi:10.1371/journal.pone.0050582.g004
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distinct from other vessels were selected for measurement. It was,
however, also noted that the vessels diameter at the bifurcation
points were larger than midway between them, and that the vessels
may not all be patent. The vessels were slightly larger than in vivo
capillary diameters which range from 5–10 mm, but otherwise in
the same range. Hence, it was evident that vascularization along
the z-axis (D) and complex features of the 3D capillary bed were a
result of the scaffolding provided by the alginate beads.
Immature microvessels tend to be thin and form slit-like
intracellular lumens completely enclosed by a single endothelial
cell (seamless capillaries) [21]. Functional microvessels, however,
show larger endothelial tube formations with complete lumens
lined by multiple endothelial cells. Confocal images taken at 406
magnification were reconstructed to give a volumetric image in 3D
(Fig. 4a). Together with x- and y-axis cross-sections (Fig. 4b), the
images showed that the capillaries had complete, multicellular
lumens which stained for actin (red) and vascular endothelial (VE)-
cadherin (green) at endothelial cell junctions. The microvessels
were also reconstructed from 156 mm z-section frames taken at
high magnification (406) in Video S1.
Flow Studies in the 3D Capillary Bed
Within alginate-collagen gels, hMVECs seeded along one
channel rapidly sprout into fully formed capillaries, lined with
multiple endothelial cells consistent with patent lumens, and reach
invasion depths of , 1.25 mm that protrude into the other
channel after 6–8 days.
To visualize the flow patterns generated within the 3D capillary
beds, devices were subject to pressure differences of a 10 mm
water column (100 Pa) with cell culture medium. High molecular
weight FITC–dextran (MW 150,000) was added to one channel
and fluorescent images were taken 5 min after dextran had
perfused through the network. A comparison of dextran profiles
before (Day 0) (Fig. 5a) and after vascularization (Day 7) (Fig. 5b)
shows the formation of a complex capillary bed that supports flow.
A representative confocal image of the flow patterns generated
from FITC–dextran perfusion in devices (Fig. 5c) was overlaid
onto images of the same network subsequently fixed and stained
for actin (red) and cell nuclei (blue) (Fig. 5d), to give a composite
image that shows the flow occurred through the immunostained
endothelial cells (Fig. 5e). The fraction of patent vessels was
calculated using confocal images similar to Fig. 5e at 106
magnification. Using images at different z-axis planes, taking care
not to select the same sprout twice, we identified 46 individual
Figure 5. Flow analysis of the 3D capillary bed. (a) Representative diffusion patterns of a MW 150,000 fluorescent dextran tracer before
vascularization (Day 0) and (b) after vascularization (Day 7). (c) Confocal images of the FITC–dextran flow patterns (green) in live devices overlaid onto
(d) images of actin (red) and cell nuclei (blue) staining to give (e) a composite image. Scale bars, 250 mm (a, b); 50 mm (c–e).
doi:10.1371/journal.pone.0050582.g005
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Figure 6. Anastamoses within the 3D capillary bed. (a) Fluorescent images of hMVECs undergoing angiogenic sprouting at Day 1–6 after
seeding. Arrows indicate the points of contact where vessels anastamose and form lumens. (b) Phase contrast images of 3D microvascular networks
in alginate-collagen gels at 46magnification and (c) 206magnification. (d) High resolution confocal images taken at Day 6 show specific sites of
anastomoses, and dotted boxes correspond to images at (e) higher magnification (VE-cadherin, green; actin, red; cell nuclei, blue). Scale bars, 250 mm
(a–d), 50 mm (e).
doi:10.1371/journal.pone.0050582.g006
Figure 7. Coculture interactions within the 3D capillary bed. (a) Fluorescent microscopy image of a microfluidic device loaded with HT-1080
alginate beads with live/dead staining (24 h after gel filling). Live cells are stained green, and dead cells are stained red. (b) Fluorescent microscopy
image of HT-1080 alginate beads in solution with live/dead staining at Day 7. (c) Phase contrast image taken on Day 1 of coculture shows the
interface between the hMVEC monolayer in the channel, and HT-1080 alginate beads within the gel region. (d) hMVEC sprout lengths were measured
as indicated by the arrows in the image. (e) hMVEC sprout lengths at 72 h after seeding in devices with alginate beads and HT-1080 alginate beads
(***, p,0.005). Scale bars, 100 mm (b); 250 mm (a, c, d).
doi:10.1371/journal.pone.0050582.g007
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sprouts that had been stained for actin and cell nuclei. All
identified vessels were #50 mm in diameter midway between
vessel bifurcation points. Next, we observed FITC–dextran
confocal images and correlated each vessel with dextran perfusion.
A total of 80.4% of vessels (37 patent, 9 non-patent; n = 46) were
observed to be patent. The true fraction of patent vessels may be
higher as the fluorescence intensity in smaller vessels may be below
detection limits.
Functional perfusion of the 3D capillary bed was demonstrated
using 1 mm diameter fluorescent microparticles. Fluorescence
time-lapse imaging of the gel region at 0.5 s intervals reveals the
perfusion of 1 mm diameter particles through well-defined and
interconnected microvessels. After concluding the flow experi-
ments, the same device was fixed and immunostained for VE-
cadherin (green) and cellular nuclei (blue), and merged with time-
lapse images (Video S2).
Examination of Anastamoses in the 3D Capillary Bed
Microvessels that develop within this microfluidic device
recapitulate a number of important angiogenic stages in vivo: cell
sprouting, migration, proliferation, lumen formation, branching,
and anastomosis [22]. Cellular sprouting processes were dynamic,
with the tip cells changing direction and branching from previous
sprouts (SI Video 3).
To visualize the anastamosing vessels, hMVECs were trans-
fected with mCherry retroviral reporter plasmids. Unlike earlier
experiments where hMVECs were seeded in one channel of the
device, here mCherry-fluorescent hMVECs were seeded in both
channels with a 12 h interval between seedings. Time-lapse images
over five days show the invasion of capillary networks from both
channels (Fig. 6a). The vessels develop an extensive 3D capillary
bed around the beads, with arrows indicating points where cells
contacted another vessel. Consistent with the hypothesis of
multiple anastomoses are visually confirmed positions where
sprout tip cells meet on Day 4 and 5 (Fig. S2). It was, however,
technically challenging to dynamically track individual sprouts in
complex 3D networks in real-time. For example, confocal images
in Fig. 6d and Fig. 6e could not be taken on Day 4 or 5 as it is a
terminal experiment with fixation and staining, and so the images
had to be taken after the sprouts that were tracked visually had
already anastamosed.
After 4–5 days, a complex 3D capillary bed of interconnected
capillary vessels was formed, with representative images taken at
46magnification (Fig. 6b) and at 206magnification (Fig. 6c).
High resolution confocal images taken of the immunostained
networks (Fig. 6d) allow us to identify specific anastomoses on
Day 6 (Fig. 6e).
Functional Properties of the 3D Capillary Bed in
Coculture with Alginate-encapsulated Cells
Finally, we investigated if the hMVECs were able to achieve
cross-talk with cells encapsulated in alginate beads, either by
responding to growth factor release, or by providing a supply of
nutrients. In this experiment, we tested whether the hMVECs
would respond to vascular growth signals secreted by a cocultured
HT-1080 human fibrosarcoma cell line. We first quantified the
potential of HT-1080s to induce angiogenesis via protein secretion
using an angiogenesis antibody array (Fig. S3). By comparing
HT-1080s against primary human dermal fibroblasts (Fig. S3a),
we showed that the HT-1080s proliferated much more rapidly
(Fig. S3b), and secreted VEGF at 2.5-fold levels over fibroblasts
after normalizing for cell number (Fig. S3c, f). Fibroblasts
secreted angiogenin [23] at four-fold levels over HT-1080s, a
factor important during physiologic angiogenesis (Fig. S3d, f). In
contrast, HT-1080s secreted placental growth factor (PIGF) [24], a
potent tumor angiogenic factor not detected with fibroblasts (Fig.
S3e, f).
Next, HT-1080 cells were encapsulated in alginate beads at a
density of 56106 cells/ml in 2% (w/v) alginate, and microinjected
as an alginate-collagen gel. The number of cells per device was
determined to be 1,3186217 cells/device (n = 8 devices). HT-1080
cell viability was quantified using live/dead staining in devices
(Fig. 7a). Cells were randomly distributed and most appeared to
be alive (green), while those along the gel boundary appeared dead
(red). Cell death at the gel-air interface may have occurred during
gel polymerization at 37uC. In addition to live/dead staining in
devices, daily viability measurements were taken from alginate-
encapsulated cells in cell medium using a trypan blue exclusion
assay (Fig. 7b). Over one week, the viability of the encapsulated
cells decreased gradually from 84.466.1% on Day 1 to
74.465.1% on Day 7 (n = 5, ,30 cells per section).
HT-1080 encapsulated alginate beads were microinjected into
the device, and hMVECs were seeded in one channel after a 24 h
interval, with the interface shown in Fig. 7c. The cell culture
medium did not contain added growth factors (e.g. FGF-b, IGF-1,
EGF, VEGF), so as to quantify angiogenic stimulation from only
the HT-1080 cell population. At 72 h after hMVEC seeding, four
of the longest sprouts were measured per device, and averaged
among n = 7 devices per condition (Fig. 7d). The longest sprout
distance for the beads-only devices was 246.10640.85 mm,
whereas the longest sprout distance for the HT-1080 bead devices
was 354.78616.88 mm (p,0.005, n = 7 devices) (Fig. 7e). As the
alginate beads also act as a physical barrier to prevent direct cell-
cell contact between the encapsulated cells and the capillary bed,
the contribution of HT-1080 to angiogenic sprouting was likely
through the secretion of growth factors such as VEGF and PIGF.
Discussion
The approach described here to engineer in vitro vascularized
tissues uses a modular scaffold comprised of two FDA-approved
biomaterials. To encourage endothelial sprouting, we delivered
chemical angiogenic stimuli using two methods: (a) stimulating
vessel growth into the scaffold with soluble angiogenic factors such
as exogenous VEGF165 [25]; and (b) stimulating vessel growth into
the scaffold by encapsulating cells that secrete angiogenic factors
[26].
There have been a number of existing strategies from our lab
and others towards the design of microvascular networks in vitro. In
principle, most of the published studies fall into two broad design
groups: the first uses a biocompatible hydrogel such as collagen I
and fibrin which is subsequently invaded by endothelial sprouts
[10,11,27]; while the second uses a sacrificial template or mold
such as poly(lactic-co-glycolic)acid (PLGA) [28], poly(glycerol
sebacate) (PGS) [29], or carbohydrate glass [30] to delineate the
channels that are later seeded with endothelial cells.
Whereas the goal of the first type of platform is typically to study
fundamental aspects of angiogenesis in vitro using methods such as
confocal microscopy and real-time imaging, these systems are
generally single-layered and are not intended for scale-up tissue
engineering applications. In the second type of platform, the
diameters of the vessels produced by sacrificial templates or molds
fall in the 50–150 mm range and larger. Vessels on that scale are
more reflective of small arterioles, versus capillaries whose
diameters are in the order of 5–10 mm in vivo. Small arterioles
designed using a template or mold are by default also pre-
patterned, meaning that they do not undergo the angiogenic
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sprouting processes that give rise to both physiologic and
pathologic capillaries.
The strength of our system lies in our ability to control the
overall blueprint of the capillary bed while still maintaining a high
degree of self-directed vessel sprouting. Not only do the alginate
beads provide the 3D architecture of the capillary bed, the vessels
also sprouted more readily when the beads were present. This
observation we believe is linked to the variable stiffness of the
matrix microenvironment, with the alginate beads having a higher
modulus than the collagen. The morphology of the vessels
produced using our approach also mimics physiologic capillaries,
such as their ,15 mm vessel diameters, multicellular lumens, and
anastomosing networks. Further, we were able to demonstrate the
vascularization of a large fraction of the z-axis (DALG–
COL = 65.569.42%) with relative ease, such that most encapsu-
lated cells are within 100–200 mm of a capillary vessel, as would be
necessary in an in vitro engineered soft tissue.
Although ,15 mm diameter vessels were plentiful and formed
the majority of capillaries, we note that these may not necessarily
all represent functional and patent vessels. Perfusion experiments
conducted with MW 150,000 fluorescent dextran in Fig. 5 and
1 mm diameter fluorescent particles in Video S2 showed the
preference for dextran and particle flow through larger vessels in
the 50–100 mm range. This is to be expected, since the larger
vessels will have the lower flow resistance. Despite the shunting
effect observed in larger vessels, fluorescent dextran still perfused a
large fraction of the ,15 mm range capillaries (Fig. 5b) and 1 mm
diameter particles also perfused smaller capillaries (Video S2).
While other studies have shown the feasibility of coculture
within vascular networks, our approach has an added advantage of
modularity. It is possible to engineer cocultures or even tricultures
by mixing alginate beads encapsulating different cell types. We
demonstrated the feasibility of coculture using HT-1080 fibrosar-
comas encapsulated in alginate beads, as these cells are highly
angiogenic and secrete a variety of angiogenic factors, including
PIGF, a potent angiogenic factor that promotes pathologic
angiogenesis [24]. Future studies may use cell types that are
beneficial in physiologic angiogenesis, such as fibroblasts [31],
smooth muscle cells, and pericytes. Mural cell types may easily be
incorporated into the devices, and the cells may cooperate with
newly formed capillaries to regulate vessel permeability and
maturation [32].
For these 3D capillary beds to be clinically useful, it will be
necessary to show viability and function beyond the two weeks
achieved in this study, especially in the presence of physiological
fluid flow. Future studies will focus on long-term vessel maturation
using growth factors such as angiopoietin-1 (Ang-1) [33] and
sphingosine-1-phosphate (S-1-P) [34], together with flow. Previous
studies suggest that the combination of these factors is likely to
stabilize vascular networks and reduce endothelial permeability in
the absence of stromal cells [35,36].
Conclusion
Functional 3D tissues in microscale devices designed with
multicellular and multimaterial compositions will soon form the
core of next generation tissue engineering approaches. In
conclusion, we envision that this vascular construct, delivered
with supportive cell populations in biocompatible scaffolds, may
have clinical applications when vascularized in the appropriate
tissue or organ-like shape, and connected to the vascular supply of
the host by anastamoses.
Supporting Information
Figure S1 Analysis of diffusion profiles in collagen and
alginate-collagen gels. (a) Diffusion profiles of fluorescent
tracers across collagen and (b) alginate-collagen gels, taken at
30 min intervals for 2 h as described in the Methods S1.
Fluorescent tracers used were DAPI–dextran (MW 10,000) (blue),
FITC–dextran (MW 40,000) (green), and Texas red–dextran (MW
70,000) (red). Temporal evolution of normalized fluorescent
intensity for collagen-only (0% v/v alginate beads, blue open
circles) and alginate-collagen (40% v/v alginate beads, red open
circles) devices using (c) 40 kDa and (d) 70 kDa dextrans. The
normalized intensity was calculated as the ratio of the value at the
midpoint between the two channels to the maximum value in the
condition channel [19]. Diffusion coefficients of the gels were
estimated by fitting the analytical solution (solid lines, blue and red
for the 0% v/v and 40% v/v gels respectively) to the measured
intensities (open circles). For collagen-only gels, diffusion coeffi-
cients for 40 and 70 kDa dextrans were:
DCOL,40 = 2.54610
211 m2/s and DCOL,70 = 2.356610
211 m2/s,
while for 40% alginate-collagen gels values were lower (hindered
diffusion): DALG–COL,40 = 2.09610
211 m2/s and DALG–
COL,70 = 1.93610
211 m2/s. Scale bar, 250 mm (a,b).
(TIF)
Figure S2 Analysis of anastomoses on Day 4 and 5 of
hMVEC sprouting. Phase contrast images taken on (a) Day 4
and (c) Day 5 show that the sprouts are invading the collagen-
alginate gels. Identical phase contrast images taken on (b) Day 4
and (d) Day 5 are reproduced with additional markings to show
the pattern of the sprouts (red) and points of contact (yellow
circles). Scale bar, 250 mm (a-d).
(TIF)
Figure S3 Cellular protein expression. (a) Phase contrast
images of cells from a HT-1080 human fibrosarcoma cell line and
human dermal fibroblasts (HDF). (b) Cellular proliferation of HT-
1080 versus HDF cells over 72 h. (c) Protein expression levels of
VEGF, (d) angiogenin, and (e) PIGF, tested by an angiogenesis
antibody array as described in the Methods S1. (f) Growth factor
secretion levels at 24 h normalized to cell number. Scale bar,
10 mm (a).
(TIF)
Video S1 3D reconstruction of a microvascular network
z-stack. Microvascular networks were imaged by confocal
microscopy at 406 magnification. Devices were fixed and
immunofluorescently labeled to detect vascular networks: VE-
cadherin on cell membranes (anti-VE-cadherin antibody, green),
cytoplasmic actin (rhodamine-phalloidin, red), and cell nuclei
(DAPI, blue). 156 z-section frames were taken at 1 mm intervals.
The video is playing at 15 frames/s. Scale bar, 50 mm.
(AVI)
Video S2 Time-lapse imaging of flow through 3D
capillary bed. The flow of fluorescent 1 mm diameter beads
through the 3D capillary bed was imaged using time-lapse
fluorescence microscopy at 106 magnification. After imaging,
devices were fixed and immunofluorescently labeled to detect
vascular networks: VE-cadherin on cell membranes (anti-VE-
cadherin antibody, green), and cell nuclei (DAPI, blue) (actin
staining in the red channel is not shown here for image clarity).
Images were taken at 500 ms intervals, and the video is playing at
6 frames/s. Scale bar, 100 mm.
(AVI)
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Video S3 Time-lapse imaging of the initial hMVEC
sprout formation. hMVEC sprout formation is a dynamic
process, and here a single hMVEC sprout probes the 3D gel
matrix by sending its filopodia in two directions from the confluent
monolayer interface, before retracting the sprout. Images were
taken using phase contrast microscopy at 106 magnification in
50 min intervals, and the video is playing at 1 frame/s. Total
movie duration: 8 h 25 min (a total of 11 frames). Scale bar,
20 mm.
(AVI)
Methods S1 Supporting Methods.
(DOC)
Acknowledgments
We thank Shannon Alford for assistance with plasmid transfection, Qing
Han for assistance with the microarray laser scanner, and Levi Wood for
discussions on the angiogenesis experiments.
Author Contributions
Conceived and designed the experiments: JMC RDK. Performed the
experiments: JMC IKZ TR WP JW. Analyzed the data: JMC IKZ TR WP
JW. Contributed reagents/materials/analysis tools: JMC JMC IKZ TR
WP JW. Wrote the paper: JMC RDK.
References
1. Johnson PC, Mikos AG, Ph D, Fisher JP, Jansen JA (2007) Strategic Directions
in Tissue Engineering. Tissue Engineering 13: 2827–37.
2. Griffith CK, Miller C, Sainson RC, Calvert JW, Jeon NL, et al. (2005) Diffusion
limits of an in vitro thick prevascularized tissue. Tissue engineering 11: 257–266.
3. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature
407: 249–257.
4. Borenstein JT, Weinberg ELIJ, Orrick BK, Sundback C, Kaazempur-mofrad
MR, et al. (2007) Review Microfabrication of Three-Dimensional Engineered
Scaffolds. Tissue Engineering 13: 1837–44.
5. Khademhosseini A, Langer R, Borenstein J, Vacanti JP (2006) Microscale
technologies for tissue engineering and biology. Proceedings of the National
Academy of Sciences of the United States of America 103: 2480–2487.
6. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, et al. (2010)
Reconstituting organ-level lung functions on a chip. Science (New York, NY)
328: 1662–1668.
7. Taylor AM, Blurton-jones M, Rhee SW, Cribbs DH, Cotman CW (2005) A
microfluidic culture platform for CNS axonal injury, regeneration and transport.
Nature Methods 2: 599–605.
8. Chung S, Sudo R, Vickerman V, Zervantonakis IK, Kamm RD (2010)
Microfluidic Platforms for Studies of Angiogenesis, Cell Migration, and Cell–
Cell Interactions. Annals of Biomedical Engineering 38: 1164–1177.
9. Zheng Y, Chen J, Craven M, Choi NW, Totorica S, et al. (2012) In vitro
microvessels for the study of angiogenesis and thrombosis. Proceedings of the
National Academy of Sciences of the United States of America 109: 9342–9347.
10. Yeon JH, Ryu HR, Chung M, Hu QP, Jeon NL (2012) In vitro formation and
characterization of a perfusable three-dimensional tubular capillary network in
microfluidic devices. Lab on a Chip 12: 2815–2822.
11. Song JW, Munn LL (2011) Fluid forces control endothelial sprouting.
Proceedings of the National Academy of Sciences of the United States of
America 108: 15342–15347.
12. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery?
Nature reviews Drug discovery 6: 273–286.
13. Folkman J, Haudenschild C (1980) Angiogenesis in vitro. Nature 288: 551–556.
14. McGuigan AP, Sefton MV (2006) Vascularized organoid engineered by modular
assembly enables blood perfusion. Proceedings of the National Academy of
Sciences of the United States of America 103: 11461–11466.
15. Glowacki J, Mizuno S (2008) Collagen scaffolds for tissue engineering.
Biopolymers 89: 338–344.
16. Cabodi M, Choi NW, Gleghorn JP, Lee CSD, Bonassar LJ, et al. (2005) A
Microfluidic Biomaterial. Journal of the American Chemical Society 127:
13788–13789.
17. Blow N (2009) Cell culture: building a better matrix. Nature Methods 6: 619–
622.
18. Xia Y, Rogers JA, Paul KE, Whitesides GM (1999) Unconventional Methods for
Fabricating and Patterning Nanostructures. Chemical Reviews 99: 1823–1848.
19. Zervantonakis IK, Chung S, Sudo R, Zhang M, Charest JL, et al. (2010)
Concentration gradients in microfluidic 3D matrix cell culture systems.
International Journal of MicroNano Scale Transport 1: 27–36.
20. Polacheck WJ, Charest JL, Kamm RD (2011) Interstitial flow influences
direction of tumor cell migration through competing mechanisms. Proceedings
of the National Academy of Sciences of the United States of America 108:
11115–11120.
21. Ba¨r T, Gu¨ldner FH, Wolff JR (1984) ‘‘Seamless’’ endothelial cells of blood
capillaries. Cell and Tissue Research 235: 99–106.
22. Folkman J (1985) Tumor Angiogenesis. Advanced Cancer Research 43: 175–
203.
23. Moenner M, Gusse M, Hatzi E, Badet J (1994) The widespread expression of
angiogenin in different human cells suggests a biological function not only
related to angiogenesis. 490: 483–490.
24. Schomber T, Kopfstein L, Djonov V, Albrecht I, Baeriswyl V, et al. (2007)
Placental growth factor-1 attenuates vascular endothelial growth factor-A-
dependent tumor angiogenesis during beta cell carcinogenesis. Cancer Research
67: 10840–10848.
25. Chung S, Sudo R, Mack PJ, Wan C-R, Vickerman V, et al. (2009) Cell
migration into scaffolds under co-culture conditions in a microfluidic platform.
Lab on a chip 9: 269–275.
26. Keshaw H, Forbes A, Day RM (2005) Release of angiogenic growth factors from
cells encapsulated in alginate beads with bioactive glass. Biomaterials 26: 4171–
4179.
27. Vickerman V, Blundo J, Chung S, Kamm R (2008) Design, fabrication and
implementation of a novel multi-parameter control microfluidic platform for
three-dimensional cell culture and real-time imaging. Lab on a chip 8: 1468–
1477.
28. King KR, Wang CCJ, Kaazempur-Mofrad MR, Vacanti JP, Borenstein JT
(2004) Biodegradable Microfluidics. Advanced Materials 16: 2007–2012.
29. Bettinger CJ, Weinberg EJ, Kulig KM, Vacanti JP, Wang Y, et al. (2006) Three-
Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible
Biodegradable Polymer. Advanced Materials 18: 165–169.
30. Miller JS, Stevens KR, Yang MT, Baker BM, Nguyen D-HT, et al. (2012) Rapid
casting of patterned vascular networks for perfusable engineered three-
dimensional tissues. Nature Materials [e-pub before print].
31. Nakatsu MN, Sainson RCA, Aoto JN, Taylor KL, Aitkenhead M, et al. (2003)
Angiogenic sprouting and capillary lumen formation modeled by human
umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts
and Angiopoietin-1. Microvascular Research 66: 102–112.
32. Darland DC, D’Amore PA (2001) Cell-cell interactions in vascular development.
Current Topics in Developmental Biology 52: 107–149.
33. Brindle NPJ, Saharinen P, Alitalo K (2006) Signaling and functions of
angiopoietin-1 in vascular protection. Circulation Research 98: 1014–1023.
34. Garcia JGN, Liu F, Verin AD, Birukova A, Dechert MA, et al. (2001)
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-
dependent cytoskeletal rearrangement. Journal of Clinical Investigation 108:
689–701.
35. Papapetropoulos A, Garcı´a-Carden˜a G, Dengler TJ, Maisonpierre PC,
Yancopoulos GD, et al. (1999) Direct actions of angiopoietin-1 on human
endothelium: evidence for network stabilization, cell survival, and interaction
with other angiogenic growth factors. Laboratory investigation a journal of
technical methods and pathology 79: 213–223.
36. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, et al. (2002)
Recombinant angiopoietin-1 restores higher-order architecture of growing blood
vessels in mice in the absence of mural cells. Journal of Clinical Investigation
110: 1619–1628.
In Vitro 3D Capillary Beds
PLOS ONE | www.plosone.org 11 December 2012 | Volume 7 | Issue 12 | e50582
